Abstract: Tissue engineering integrates discoveries from biochemistry, cell and molecular biology, material science and biomedical engineering to produce innovative three-dimensional composites that can be used to replace or correct damaged tissues and organs. Precise classification of osteoinductive properties of human demineralised bone is often the problem, because it varies from batch to batch. An in vitro assay using bone marrow derived human mesenchymal stromal cells (hMSCs) was developed to improve the classification of the osteoinductive quality of demineralised bone matrix. In this study, three-dimensional, partially demineralised bone scaffolds were investigated for their ability to induce osteogenic differentiation of hMSCs in vitro. Proliferation of the hMSCs was measured by the CelTiter 96 AQueous One Solution Cell assay. Chemical structure was evaluated using quantitative and qualitative X-ray analysis. Scanning electron microscopy revealed primary proliferation of the cells cultivated 14 days and showed elevations in the content of Ca
Introduction
Current tissue engineering methods for the repair of skeletal defects have the overall goal of the regeneration of tissue. Recent research has focused on developing new approaches for generating tissues in vitro that maintain the phenotype of the cells and promote three-dimensional histogenesis. These methods usually involve cell carriers or scaffolds because monolayer culture does not replicate the architecture of tissues and organs (Mizuno & Glowacki 1996) . New methods are needed to assess the ability of three-dimensional implants to integrate successfully in vivo.
Depending on the source of the implant biomaterial, many factors affect the effectiveness of the clinical bone repair. Problems arise because of mismatches between the mechanical properties of the implant and the surrounding tissues, limited porosity, inflammation responses, mechanical instability during loading, and inconsistent rates of degradation. Biomaterials designed as the cell-based scaffolds provide a site for the attachment of anchorage-dependent osteoprogenitors, and support or promote osteogenic differentiation in vitro to allow for the development of an osteoblastic phenotype and deposition of new bone matrix. Demineralised bone block and matrices are potentially attractive scaffolds for use in tissue engineering because they have the capacity to support and promote in vivo osteogenesis of the bone matrix. Allogenic or alloplastic materials are biocompatible, not infective, resorbable, osteoconductive, and osteoinductive. These grafts can either be cancellous or cortical in nature. Both variants allow the revascularization and the migration of bone forming and resorbing cells onto and into the tissue (Wildemann et al. 2007) . Bone marrow derived osteoprogenitors combined with demineralised bone block 1248 S. Gromošová et al.
and matrices have been demonstrated to accelerate and enhance bone formation within osseous defects when compared with the matrix alone (Mauney et al. 2004) .
Human mesenchymal stromal cells (hMSCs) isolated from bone marrow have been used to facilitate bone repair in various osseous defect models (Im et al. 2001) . There is potential for the aspirated cells to be grown on allograft for a time supplemented with osteogenic supplement to ensure production of extracellular matrix before grafting in ortopaedic procedures (Rust et al. 2007) .
Mesenchymal stromal cells (MSCs) must be plastic adherent when maintained in standard culture conditions, must express CD105, CD73 and CD90 and lack expression of CD45, CD34, CD14 or CD19 and HLA-DR surface molecules and must differentiate to osteoblasts, adipocytes and chondroblasts in vitro (Huss 2000; Dominici et al. 2006) . MSCs isolated from the bone marrow are capable of self-renewal; however, there are some limitations to the use of MSCs for tissue engineering and repair. One limitation is a reduction of the capacity of the stromal cells for self-renewal with increasing age and a decrease in their potential to proliferate and to differentiate into specific cell types (Rosocha et al. 2005) . The goal of this project is to determine the effect of different formulations of bone materials on osseogenesis. Optimal use of the bone grafts scaffolds may overcome the reduction of stromal cell proliferation.
Material and methods

Preparation of bone samples
Four different groups of osteoinductive material were prepared from the femoral condyles of cadaveric tissue donors. The bone samples were collected respecting all ethical criteria for tissue banking. The four groups are described below: CBB1 (control cancellous bone blocks) (3×3×3 mm) were rinsed with distilled water at room temperature for 1 h and defatted with distilled water in a water bath at 50
• C for 1 h. Finally, the samples were treated in 90% ethanol and dried at 50
• C. CBB2 (treated cancellous bone blocks) (3×3×3 mm) were rinsed with distilled water at room temperature for 1 h and defatted with distilled water in a water bath at 50
• C for 1 h. Subsequently, red blood cells were removed by use of 0.07 M sodium phosphate dodecahydrate at room temperature for 16 h, then rinsed with distilled water for 1 h and sterilized by the use of a mixture of 0.36 M peracetic acid, 4.40 M ethanol, and 5.14 M propylene glycol in distilled water for 24 h at room temperature. The material was subsequently rinsed with distilled water and with 0.15 M NaCl. Finally, the samples were dehydrated in ethanol and dried out at 50
• C for 2 h. DCBB (demineralised cancellous bone blocks) (3×3×3 mm) were prepared the same way as samples CBB2. Subsequently, demineralisation was performed using by 0.5 M HCl in distilled water at 4
• C for 2 h. DBM (demineralised bone matrix) was prepared in the same way as samples DCBB. Blocks were subsequently milled. DBM was prepared in powder consistence.
Human mesenchymal stromal cells isolation and culture hMSCs are pluripotent progenitor cells found in bone marrow. The procedures for the isolation and in vitro culture of the hMSCs used in this study are described as follows: 1 mL of medium I -Dulbecco's PBS medium (Gibco BRL , containing 800 units/mL of heparin, 100 units/mL of penicilin, 100 mg/mL of streptomycin and 0.25 mg/mL of amphotericin B was used for bone marrow aspiration. A Jamshidi bone marrow biopsy needle (Allegiance Health-care Corp., USA) was used for bone marrow collection. Two mL of bone marrow were aspirated from the iliac crest of the donor. Immediately after disconnecting the needle, its content were mixed and transferred to a tube with ice cold and placed into melting ice. Medium II -contains Dulbecco's PBS medium (Gibco BRL , 2% of bovine foetal serum, 20 units of heparin and the same concentration of antibiotics as in medium I and placed into melting ice. Typically two or a maximum of three bone marrow aspirations were needed to collect a sufficient amount of MSCs.
The bone marrow cells were processed according to the method of Pittenger et al. (1999) . Briefly, the sample was centrifuged at 200×g for 15 min/4
• C, the pellet isolated and gently mixed with cold sterile lysing solution (0.826 g NH4Cl, 0.1 g KHCO3, 0.004 g EDTA in 100 mL). The solution added in the ratio of one part of cell suspension to four parts of lysing solution. The mixture was gently mixed and placed in melting ice for 10 min. Two volumes of cold MEM alpha medium or Dulbecco's PBS were added, gently mixed and centrifuged at 200×g for 15 min at 4
• C. Finally, the cells were counted and viability estimated. The cell pellet after the last spin was re-suspended in 25 mL of complete cultivation medium (MEM alpha, 10% foetal bovine serum, 10% of patient's serum, antibiotics) and seeded into two 75 cm 2 culture flasks for adherent cell cultures. The cell suspension was incubated in the atmosphere of 95% air, 5% carbon dioxide at 37
• C until the cells were adherent to the plastic support of the flasks, every 3-4 days suspended cells were removed and a completely new medium added according to the cellular metabolism. The medium was changed and cultivation continued until a monolayer was formed. When osteoclastic-multinuclear cells occur in a culture, "quicker" passage was needed to eliminate damage to the future mesenchymal colonies. Cells -hMSCs can typically be grown for more than 5-10 subcultures without a change of phenotype or reduction in growth quality. Under light microscopy, the hMSCs cultures display a homogenous population of fibroblast-like cells. These cells are normally present at very low frequency in bone marrow: 2-5 MSCs per 1×10
6 of mononuclears cells, but this number is dependent on the age and treatment history of the bone marrow donor (Rosocha et al. 2005 ).
Co-cultivation of MSCs with demineralised bone material Demineralised bone samples DBM and DCBB and hMSCs (3.5×10 4 /well) were placed into the 96 well plate and cultivated in 200 µL of complete cultivation medium at 37
• C, in 5% of CO2 for 24 h according to the scheme (Fig. 1) . Four hours later, bone blocks with the seeded cells were transferred into new wells. Cultivation continued for two weeks, the medium was changed 3 times weekly.
Cell proliferation assay
The CellTiter 96 AQueous One Solution cell proliferation assay (Promega Corporation, Madison, WI, USA) was used to measure the proliferative activity of the cells cultivated with DCBB and DBM samples. Optical density of the Fig. 1 . Scheme of the cell proliferation assay. Legend: column 1, cultivation medium-negative control 1; column 2: DBM without the cells-negative control 2; columns 3 and 4, hMSCs (3.5 × 10 4 /well)-positive control; columns 6 and 7, hMSCs (3.5 × 10 4 /well) + DBM; columns 9 and 10, hMSCs (3.5 × 10 4 /well) + DCBB; columns 5, 8, 11 and 12: empty.
coloured supernatant was measured at 490 nm with a reference filter at 630 nm.
Scanning electron microscopy
At the end of the cultivation period, the cell carriers DCBB with MSCs were fixed with 2% glutaraldehyde and then post-fixed in 1% osmium tetroxide. The samples (CBB1, CBB2, DCBB) were dehydrated in a graded series of ethanol and dried in a carbon dioxide incubator. Samples without DBM were then visualized by scanning electron microscope (JEOL JSM 35-CF equipped with an X-ray analyser LINK AN 10/85S, Japan).
Statistical analysis
Data obtained in the cell proliferation assay and in the quantitative X-ray analysis were expressed by mean ± standard deviation.
Results and discussion
The proliferation of the MSCs was measured by the CellTiter 96 AQueous One Solution cell proliferation assay for each experimental group. The differences between individual groups are shown in Figure 2 . Bone materials (DBM and DCBB) enhanced proliferation of hMSCs by approximately 40% following two weeks of incubation. Cells grown without the addition of any material except the complete cultivation medium were used as the control. Neither bone material significantly affects bone growth compared with controls for a 1-week incubation period.
For the confirmation of cell adhesion and proliferation in human demineralised cancellous blocks, scanning electron microscopy and quantitative X-ray analysis for elements was performed for all samples (CBB1, CBB2, DCBB, DCBB with MSCs). These results are shown in Figure 3 , and the X-ray analysis in Table 1 .
The demineralised cancellous bone block with hMSCs exhibited a significantly higher calcium level after 14 days of cultivation compared with the demineralised cancellous bone block incubated without hMSCs. DBM is being used successfully in many craniomaxillofacial, orthopedic, periodontal, and hand reconstruction procedures (Zhou et al. 2005) . Since the initial studies performed by Urist (2002) , the osteoinductive capacity of DBM has been well established. DBM is produced by the acid extraction of human cortical bone. The bioactive components of the bone that remain behind include: non-collagenous proteins; bone osteoinductive growth factors, the most significant of which is BMPs; and type I collagen DBM which provides no structural strength, and its primary use is in a structurally stable environment (Parikh 2002) .
DBM and demineralised cancellous bone are the type I collagenous DBM attractive scaffolds for use in tissue engineering because of their ability to support and promote the in vivo osteogenesis of matrix incorporated osteoprogenitors. Human MSCs have been used in research for tissue engineering of bone on scaffolds. Kasten et al. (2003) , for example, used hMSCs obtained from adult donors (18-50-year-old) to compare three resorbable biomaterials for cell penetration into the matrix, cell proliferation, and osteogenic differentiation. They also reported that DBM seemed to be more favourable than calcium-deficient hydroxyapatite and β-tri-calcium phosphate in support later of stages of osteoblast differentiation in vitro. In addition, Mauney et al. (2004) found that mechanical stimulation promotes osteogenic differentiation of hMSCs on partially demineralised bone scaffolds in vitro.
The osteoblastic differentiation of mesenchymal stromal cells observed in this study in the presence of demineralised cancellous bone material provides direct confirmation that DBM stimulates hMSCs to osteoblastic differentiation and to production of new bone. The molecules present in the demineralised bone are attractive for human bone marrow derived MSCs. Demineralized bone can also enhance proliferation of pluripotent MSCs, what means that MSCs can grow on surface of bone and can produce mineralised extracellular matrix (Han et al. 2003; Alhadlaq & Mao 2004 ). This in vitro test was developed to eliminate testing of osteoinductive properties of demineralised bone grafts on animals. As our results show, proliferation of hMSCs was enhanced in the presence of human demineralised cancellous bone powder and human demineralised cancellous bone blocks after two-week cultivation. These results confirm that material used in the test retains its desirable bioactive osteoinductive properties during the whole processing and manipulation. This fact was also confirmed by the scanning electron microscopy study, where MSCs were visualized well attached and proliferating without any morphological changes and were shown to be also forming new extracellular matrix rich in calcium and phosphorous. The CellTiter 96 AQueous One Solution cell proliferation assay was shown to be effective for characterization of the proliferation of hMSCs in the presence of biomaterials such as DBM or demineralised cancellous bone blocks. The cell distribution was uniform in the demineralisation cancellous bone block as visualized by scanning electron microscopy.
Conclusion
The hMSCs used in our study enriched the content of calcium and phosphorous in demineralised cancellous bone matrix by co-cultivation. According to our measurements the calcium content was enhanced in comparison to demineralised bone material into a level of more than 70% while the phosphorous was increased more than 20%. These results confirm that bone grafts sterilised by our chemical method are non-toxic for hMSCs and the chemical sterilization of the bone grafts enhances osteoinductive properties of the donor demineralised cancellous bone biomaterial. Human MSCs were also shown to be capable to attach to the surface of the cancellous bone material giving direct evidence that this material is also attractive for MSCs. We believe that testing of the osteoinductive quality of different bone grafting material by using human bone marrow derived MSCs has the potential to replace the animal in vivo testing of osteoinductive quality of DBM matrix and that it will also help to further studies of osteogenesis.
